I’m sure Pfizer buying a pharmaceutical company, after the rollout of the C19 shot, that specializes in cardiovascular treatments and medicine, as well as getting approval on their first “gene therapy” for blot clots, was just a mere coincidence.
— ZNO 🇺🇸 (@therealZNO) May 7, 2024
It’s not about OUR collective… pic.twitter.com/FCVqqlpixI